| Net Cash Provided by (Used in) Operating Activities |
$7,014 |
USD |
|
Q3 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$10,270 |
USD |
-111% |
Q3 2024 |
Q1 2025 |
| Common Stock, Shares, Issued |
4,806,565,324 |
shares |
|
Q3 2024 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$3,287 |
USD |
-79% |
Q3 2024 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$33,432,144 |
USD |
|
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$32,463,042 |
USD |
|
Q3 2024 |
Q1 2025 |
| Additional Paid in Capital |
$24,408,789 |
USD |
-7.7% |
Q3 2024 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2024 |
Q1 2025 |
| Interest Expense |
$71,842 |
USD |
-44% |
Q3 2024 |
Q1 2025 |